✦ LIBER ✦

Use ofIn VivoAnimal Models to Assess Pharmacokinetic Drug-Drug Interactions

✍ Scribed by Cuyue Tang; Thomayant Prueksaritanont

Book ID: 106493980
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 304 KB
Volume: 27
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-010-0157-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of Drug Interactions Relevant

Assessment of Drug Interactions Relevant to Pharmacodynamic Indirect Response Models

✍ Justin Earp; Wojciech Krzyzanski; Abhijit Chakraborty; Miren K. Zamacona; Willia 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 630 KB

Power estimation using a population phar

Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies

✍ Shuying Yang; Misba Beerahee 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 249 KB

Stereochemical aspects of warfarin drug

Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic-pharmacodynamic model

✍ Chan, Eli; Mclachlan, Andrew; O'reilly, Robert; Rowland, Malcolm 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 751 KB

Microdosing Assessment to Evaluate Pharm

Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in Rats Using Liquid Chromatography-Tandem Mass Spectrometry

✍ Jinsong Ni; Hui Ouyang; Mauro Aiello; Carmai Seto; Lisa Borbridge; Takeo Sakuma; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB

A priori prediction of tissue:plasma par

A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery

✍ Patrick Poulin; Frank-Peter Theil 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 3 views

The tissue:plasma (P t:p ) partition coefficients (PCs) are important drugspecific input parameters in physiologically based pharmacokinetic (PBPK) models used to estimate the disposition of drugs in biota. Until now the use of PBPK models in early stages of the drug discovery process was not possib

Utility of a physiologically–based pharm

Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

✍ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4